Nureca · NSE: NURECA · BSE: 543264

Q4 FY26 results · Jan–Mar 2026

Nureca reported revenue from operations of ₹35.41 crore (up 11.5% from Q4 FY25) and net loss of ₹6.09 crore for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations35.4131.74+11.5%39.64−10.7%
Other income1.021.99−49.0%2.19−53.6%
Total income36.4233.73+8.0%41.83−12.9%
Profit before tax(5.51)2.05Turned loss4.66Turned loss
Net profit for the period(6.09)2.47Turned loss3.73Turned loss
EPS, basic (₹)(6.45)2.47Turned loss3.91Turned loss
Net margin (%)-17.27.89.4
Standalone · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations35.4131.75+11.5%39.64−10.7%
Other income1.062.00−46.8%2.29−53.5%
Total income36.4733.75+8.1%41.92−13.0%
Profit before tax(6.15)1.50Turned loss4.05Turned loss
Net profit for the period(6.62)2.07Turned loss3.23Turned loss
EPS, basic (₹)(6.95)2.07Turned loss3.39Turned loss
Net margin (%)-18.76.58.2
Consolidated
Filed with BSE
29 May 2026, 21:29 IST
Board meeting
29 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
29 May 2026, 21:29 IST
Board meeting
29 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE